The breast-conserving surgery market size was valued at USD 2.36 billion in 2024 and is expected to reach USD 4.18 billion by 2032, growing at a CAGR of 7.47% over the forecast period of 2025-2032.
The global breast-conserving surgery market is expected to grow at a steady rate due to the increasing awareness of breast cancer screening and early diagnosis. The trend toward less invasive surgery with favorable cosmetic results is motivating patients to select lumpectomy and segmental mastectomy rather than complete mastectomy. Emerging technologies that improve tumor localization, intraoperative imaging, and margin assessment are broadening the scope of precision surgery. Meanwhile, an increasing number of healthcare policies, insurance coverage, and oncological guidelines supporting the use of breast-conserving procedures further facilitate the adoption of breast-conserving procedures globally.
The U.S. breast-conserving surgery market size was valued at USD 0.69 billion in 2024 and is expected to reach USD 1.19 billion by 2032, growing at a CAGR of 7.14% over the forecast period of 2025-2032.
North America breast-conserving surgery dominated the market, contributing to the growth in the U.S. due to higher healthcare expenditure, widespread uptake of breast cancer screening programs that are effective at the early stages of breast cancer, and wide availability and accessibility of minimally invasive surgical technology. The country is further bolstered in its lead in the region by strong adoption of intraoperative imaging and tumor localization devices, coupled with a favorable reimbursement framework.
Through pooled data from nearly 1.2 million mammograms between Germany and the U.S., a combination of artificial intelligence (AI) and radiologist review increased breast cancer detection rates by 2.6% over radiologist review alone. Their findings were reported in July 2022 in The Lancet Digital Health.
Drivers:
The key factor responsible for fueling the breast-conserving surgery market trends is the rising incidence of breast cancer in the elderly population, especially above the age of 40 years globally. The increasing awareness about breast cancer and improved screening facilities have led to an upsurge in early-stage diagnosis (Stage 0–II). These early detections allow patients to qualify for breast-saving procedures, such as lumpectomy, which seeks to excise the tumor while retaining most, if not all, of the breast. If breast cancer continues to grow in incidence globally, then the need for effective and less disfiguring surgical solutions would also grow.
The NIH estimates that by 2040, breast cancer incidence will be well over 3 million new cases, up from 2.3 million in 2020 globally, indicating an ever-increasing need for early detection and breast-conserving surgical (BCS) procedures.
Since, in early-stage breast cancer, almost two-thirds of patients now opt for lumpectomy, and nearly six in ten hospitals in the developed countries are using image-guided lumpectomy nowadays.
Breast-conserving surgeries have been revolutionized, as technological innovations are improving the precision of breast surgeries and how safe it is to treat cancers while leaving the breast intact. For instance, wireless tumor localization systems (SCOUT and Magseed), intraoperative imaging, and real-time margin assessment devices enable surgeons to precisely locate and remove tumors while sparing healthy tissue. These tools help mitigate the chance of repeated surgeries and enhance patient outcomes. Continued advancement of image-guided surgery, coupled with energy-based dissection instruments, further increases confidence in the BCS technique, allowing for wide uptake of BCS in the hospital and ambulatory settings.
Moreover, another publication in Nature (2020) found that analyzing over 91,000 mammograms from the U.S. and the U.K. demonstrated that the use of AI was associated with significantly lower false-positive rates, nearly a 6% lower in the U.S. and 1.2% lower in the U.K., which also supports its role in improving early diagnosis.
Restraints:
The cost factor is one of the key restraints in the breast-conserving surgery market growth, which further refers to the combined cost of advanced surgical procedures and technologies. Advancements, including wireless tumor localization, intraoperative imaging, margin assessment tools, and oncoplastic surgery, require costly instruments and distinct skills, which divert revenue and increase costs associated with the primary procedure. In most areas, especially in developing countries, these expenses are not captured by public or private insurance systems, leading to out-of-pocket costs for patients. Moreover, the upkeep and utilization of these high-tech devices increase the institutional cost, making it less appealing for smaller clinics and a few hospitals to adopt them. The high costs of hardware thus restrict the people who can most benefit from BCS from accessing it at scale.
By Procedure
In 2024, the lumpectomy segment dominated the breast-conserving surgery market, holding the largest share with 42.16% due to lumpectomy being the most common procedure performed for early breast cancer treatment. A partial mastectomy, or lumpectomy, is a procedure in which only the tumor and a narrow margin of surrounding tissue are removed, leaving most of the affected breast in place. It provides clinical results comparable to mastectomy but with less physical and emotional trauma, hence it has become the preferred treatment among many patients and physicians. Moreover, high-end localization and imaging tools have increased the surgical precision and outcome, thereby strengthening their position.
The quadrantectomy segment is anticipated to exhibit the fastest CAGR throughout the forecast period, owing to a higher availability of high-risk patients with a higher demand for extensive tumor resection. Quadrantectomy is the surgical excision of larger parts of breast tissue, and in some cases, it may also help reduce the chances of the cancer recurring. The increase in local market adoption of this procedure is driven by improving surgical methods, resources, enhanced intraoperative imaging precision, and increasing use in the setting of multifocal or other more aggressive tumor characteristics. With changing patient education and commitment from oncologists, quadrantectomy is coming into prominence as an aggressive option for breast conservation.
By Product
The breast-conserving surgery market share in 2024 was led by the surgical excision devices segment with 43.16%, as these devices are used primarily to excise the cancerous tissue whilst ensuring minimal damage to the surrounding normal tissue. Such devices, from sophisticated scalpels and electrosurgical and radiofrequency instruments, are used in both standard-of-care lumpectomies and breast-conserving operations. They are invaluable due to their ability to achieve clean surgical margins and their functional role in reducing recurrence risk. They have consolidated a leading market position due to they are broadly available in most hospitals and surgical centers, and there is a steady clinical requirement for such devices.
The tumor localization devices segment is expected to register the highest growth during the forecast period, owing to a high focus on specific pre-surgical planning and accuracy. These include tools, such as magnetic seeds, radar reflectors, and radiofrequency identification (RFID) that enable surgeons to find the location of difficult-to-palpate tumors before surgical removal. With earlier diagnosis of breast cancer through screening, localization tools have become essential to excise the tumor completely while maximizing preservation of healthy tissue. Recent technological advancements, better patient comfort, and replacing wire localization with a wireless method are some of the factors leading to widespread adoption across health care systems.
By End-Use
The hospitals segment held the largest share of the breast-conserving surgery market in 2024, with a 78.05%, owing to their comprehensive surgical infrastructure, availability of multidisciplinary oncology teams, and access to advanced imaging and excision technologies. With a focus on post-operative care, diagnosis, and treatment, hospitals remain the leading institutions for performing these complex and early-stage breast cancer surgery types, such as quadrantectomy and lumpectomy. Furthermore, their expertise in complication management, intraoperative margin evaluation, and integrated radiotherapy and chemotherapy assistance can further substantiate the leadership of breast-conserving surgery by these centers.
The ambulatory surgery centers (ASCs) segment is anticipated to be the fastest growing segment during the forecast period, as the demand for economical and rapid recovery, and minimally invasive surgical solutions will likely rise during the forecast years. Ambulatory surgical center (ASC) placements yield high efficiency with minimal postoperative hospital stays in addition to decreased healthcare costs, and have gained acceptance for management of early-stage breast cancer. New technology for surgical instruments and imaging has allowed many complex procedures, such as breast-conserving surgeries, to be performed safely as outpatient procedures.
North America dominated the breast-conserving surgery market with a 38.2% market share in 2024, owing to the advantages of a well-established health care infrastructure, high awareness regarding breast cancer screening, and early detection initiatives. The routine availability of novel diagnostic and surgical technologies, including intraoperative imaging and tumor localization systems, increases the accuracy and safety of breast-saving operations. Coupled with robust insurance coverage and favorable reimbursement policies in the U.S. and Canada, it has made the procedure more widely available. Moreover, the high investment in breast cancer research and the presence of key medical device players also support the dominance in the North American market.
Increasing incidence of breast cancer, increasing healthcare expenditure, coupled with rising accessibility to surgical care, are the factors that are expected to speed up the growth of the breast-conserving surgery market in the Asia Pacific region with an 8.12% CAGR over the forecast years. In response to improved awareness of early diagnosis by national screening programs, countries such as China, India, and Japan are increasingly employing breast-conserving techniques. The private healthcare infrastructure expansion, government-induced cancer control initiatives, and the rise of innovative surgical devices in the emerging countries also promote growth further. This is further accelerating regional adoption with increasing focus on patient quality of life and improved post-surgical outcomes.
The breast-conserving surgery market in Europe is witnessing significant growth attributed to the presence of developed healthcare systems, region-wide breast cancer screening programs, and a steady rise in females preferring minimally invasive treatment. Breast-conserving surgery is being driven in countries such as Germany, France, and the U.K. due to the introduction of new technologies in advanced imaging, tumor localization, and margin assessment for better surgical procedures.
Furthermore, increased focus on cosmetic results and quality of life in the post-operative scenario encourages the use of oncoplastic methods. The increasing support for the improvement of breast-conserving surgery across the European region is facilitated through the rise in R&D investment, along with favorable clinical guidelines, alongside government-supported cancer care initiatives.
The breast-conserving surgery market analysis in Latin America and the Middle East & Africa (MEA) is growing substantially, owing to increasing awareness about breast cancer and boosting accessibility to healthcare services. The countries' oncology infrastructure and screening programs are gradually developing, thus offering a higher chance to get breast cancer diagnosed at an early stage, which is a crucial opportunity when performing breast-conserving procedures. Such regions are accompanied by growth limitations due to the challenges of outdated surgical technologies, urban–rural access inequalities, and the limited budget in public health systems. However, investments under healthcare modernization, along with the rising demand for minimally invasive surgical options, are anticipated to continue ensuring market growth opportunities over the foreseeable future.
Key Players:
The breast-conserving surgery market companies, Hologic, BD (Becton, Dickinson and Company), Danaher Corporation, Carl Zeiss Meditec AG, Merit Medical Systems, Argon Medical Devices, Endomagnetics Ltd., SOMATEX Medical, Ranfac Corporation, Stryker Corporation, and other players.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 2.36 Billion |
| Market Size by 2032 | USD 4.18 Billion |
| CAGR | CAGR of 7.47% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Procedure (Lumpectomy, Quadrantectomy, Segmental Mastectomy) • By Product (Tumor Localization Devices, Surgical Excision Devices, Margin Assessment Devices, Intraoperative Imaging & Navigation Devices) • By End Use (Hospitals, Ambulatory Surgery Centers, Oncology/Specialty Clinics, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Hologic, BD (Becton, Dickinson and Company), Danaher Corporation, Carl Zeiss Meditec AG, Merit Medical Systems, Argon Medical Devices, Endomagnetics Ltd., SOMATEX Medical, Ranfac Corporation, Stryker Corporation, and other players. |
Ans: The Breast-Conserving Surgery Market is expected to grow at a CAGR of 7.47% from 2025 to 2032.
Ans: The Breast-Conserving Surgery Market was USD 2.36 billion in 2024 and is expected to reach USD 4.18 billion by 2032.
Ans: Advancements in surgical technologies are propelling the market growth.
Ans: Hologic, BD (Becton, Dickinson and Company), Danaher Corporation, Carl Zeiss Meditec AG, Merit Medical Systems, Argon Medical Devices, Endomagnetics Ltd., SOMATEX Medical, Ranfac Corporation, Stryker Corporation, and other players.
Ans: North America dominated the breast-conserving surgery market in 2024.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2024)
5.2 Procedural & Treatment Trends (2024), by Region
5.3 Healthcare Spending and Reimbursement Trends, by Region (2024)
5.4 Technological Integration and R&D Trends (2024–2032)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Breast-Conserving Surgery Market Segmentation By Application
7.1 Chapter Overview
7.2 Lumpectomy
7.2.1 Lumpectomy Market Trends Analysis (2021-2032)
7.2.2 Lumpectomy Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Quadrantectomy
7.3.1 Quadrantectomy Market Trends Analysis (2021-2032)
7.3.2 Quadrantectomy Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Segmental Mastectomy
7.4.1 Segmental Mastectomy Market Trends Analysis (2021-2032)
7.4.2 Segmental Mastectomy Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Breast-Conserving Surgery Market Segmentation By Product
8.1 Chapter Overview
8.2 Tumor Localization Devices
8.2.1 Tumor Localization Devices Market Trend Analysis (2021-2032)
8.2.2 Tumor Localization Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.3 Wire-guided localization
8.2.3.1 Wire-guided localization Market Trend Analysis (2021-2032)
8.2.3.2 Wire-guided localization Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.4 Magnetic seed localization
8.2.4.1 Magnetic seed localization Market Trend Analysis (2021-2032)
8.2.4.2 Magnetic seed localization Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.5 Radar-based localization
8.2.5.1 Radar-based localization Market Trend Analysis (2021-2032)
8.2.5.2 Radar-based localization Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.6 Others
8.2.6.1 Others Market Trend Analysis (2021-2032)
8.2.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Surgical Excision Devices
8.3.1 Surgical Excision Devices Market Trends Analysis (2021-2032)
8.3.2 Surgical Excision Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3.3 Electrosurgical units/devices
8.3.3.1 Electrosurgical units/devices Market Trends Analysis (2021-2032)
8.3.3.2 Electrosurgical units/devices Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3.4 Scalpels/forceps/retractors/clamps
8.3.4.1 Scalpels/forceps/retractors/clamps Market Trends Analysis (2021-2032)
8.3.4.2 Scalpels/forceps/retractors/clamps Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3.5 Vacuum-assisted biopsy systems
8.3.5.1 Vacuum-assisted biopsy systems Market Trends Analysis (2021-2032)
8.3.5.2 Vacuum-assisted biopsy systems Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3.6 Other
8.3.6.1 Other Market Trends Analysis (2021-2032)
8.3.2 Other Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Margin Assessment Devices
8.4.1 Margin Assessment Devices Market Trends Analysis (2021-2032)
8.4.2 Margin Assessment Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Intraoperative Imaging & Navigation Devices
8.5.1 Intraoperative Imaging & Navigation Devices Market Trends Analysis (2021-2032)
8.5.2 Intraoperative Imaging & Navigation Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Breast-Conserving Surgery Market Segmentation By End User
9.1 Chapter Overview
9.2 Hospitals
9.2.1 Hospitals Market Trends Analysis (2021-2032)
9.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Ambulatory Surgery Centers
9.3.1 Ambulatory Surgery Centers Market Trends Analysis (2021-2032)
9.3.2 Ambulatory Surgery Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Oncology/Specialty Clinics
9.4.1 Oncology/Specialty Clinics Market Trends Analysis (2021-2032)
9.4.2 Oncology/Specialty Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Others
9.5.1 Others Market Trends Analysis (2021-2032)
9.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Breast-Conserving Surgery Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.2.3 North America Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.2.4 North America Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.2.5 North America Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.2.6.2 USA Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.2.6.3 USA Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.2.7.2 Canada Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.2.7.3 Canada Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.2.8.2 Mexico Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.2.8.3 Mexico Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3 Europe
10.3.1 Trends Analysis
10.3.2 Europe Breast-Conserving Surgery Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.3 Europe Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.3.4 Europe Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.5 Europe Breast-Conserving Surgery Market Estimates and Forecasts, By End User(2021-2032) (USD Billion)
10.3.6 Germany
10.3.1.6.1 Germany Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.3.1.6.2 Germany Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.1.6.3 Germany Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.7 France
10.3.7.1 France Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.3.7.2 France a Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.7.3 France Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.8 UK
10.3.8.1 UK Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.3.8.2 UK Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.8.3 UK Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.9 Italy
10.3.9.1 Italy Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.3.9.2 Italy Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.9.3 Italy Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.10 Spain
10.3.10.1 Spain Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.3.10.2 Spain Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.10.3 Spain Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.12 Poland
10.3.12.1 Poland Breast-Conserving Surgery Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.12.1 Poland Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.3.12.3 Poland Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.12.3 Poland Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.13 Turkey
10.3.13.1 Turkey Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.3.13.2 Turkey Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.13.3 Turkey Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.14 Rest of Europe
10.3.14.1 Rest of Europe Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.3.14.2 Rest of Europe Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.3.14.3 Rest of Europe Breast-Conserving Surgery Market Estimates and Forecasts, By End User(2021-2032) (USD Billion)
10.4 Asia-Pacific
10.4.1 Trends Analysis
10.4.2 Asia-Pacific Breast-Conserving Surgery Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.4.3 Asia-Pacific Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.4.4 Asia-Pacific Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.4.5 Asia-Pacific Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.4.6.2 China Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.4.6.3 China Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.4.7.2 India Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.4.7.3 India Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.4.8.2 Japan Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.4.8.3 Japan Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.4.9.2 South Korea Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.4.9.3 South Korea Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.10 Singapore
10.4.10.1 Singapore Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.4.10.2 Singapore Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.4.10.3 Singapore Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.11 Australia
10.4.11.1 Australia Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.4.11.2 Australia Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.4.11.3 Australia Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.12 Rest of Asia-Pacific
10.4.12.1 Rest of Asia-Pacific Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.4.12.2 Rest of Asia-Pacific Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.4.12.3 Rest of Asia-Pacific Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Trends Analysis
10.5.2 Middle East and Africa East Breast-Conserving Surgery Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.5.3Middle East and Africa Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.5.4 Middle East and Africa Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.5.5 Middle East and Africa Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.6 UAE
10.5.6.1 UAE Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.5.6.2 UAE Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.5.6.3 UAE Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.7 Saudi Arabia
10.5.7.1 Saudi Arabia Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.5.7.2 Saudi Arabia Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.5.7.3 Saudi Arabia Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.8 Qatar
10.5.8.1 Qatar Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.5.8.2 Qatar Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.5.8.3 Qatar Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.9 South Africa
10.5.9 1 South Africa Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.5.9 2 South Africa Breast-Conserving Surgery Market Estimates and Forecasts By Product (2021-2032) (USD Billion)
10.5.9 3 South Africa Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.10 Rest of Middle East & Africa
10.5.10.1 Rest of Middle East & Africa Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.5.10.2 Rest of Middle East & Africa Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.5.10.3 Rest of Middle East & Africa Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Breast-Conserving Surgery Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.6.3 Latin America Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.6.4 Latin America Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.6.5 Latin America Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.6.6.2 Brazil Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.6.6.3 Brazil Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.6.7.2 Argentina Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.6.7.3 Argentina Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6.8 Rest of Latin America
10.6.8.1 Rest of Latin America Breast-Conserving Surgery Market Estimates and Forecasts, By Procedure (2021-2032) (USD Billion)
10.6.8.2 Rest of Latin America Breast-Conserving Surgery Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)
10.6.8.3 Rest of Latin America Breast-Conserving Surgery Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
12. Company Profiles
12.1 Hologic,
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.2 BD (Becton, Dickinson and Company)
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.3 Danaher Corporation
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.4 Carl Zeiss Meditec AG
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.5 Merit Medical Systems
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.6 Argon Medical Devices
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.7 Endomagnetics Ltd.,
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.8 SOMATEX Medical
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.9 Ranfac Corporation
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.10 Stryker Corporation
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysi
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Procedure
By Product
By End Use
Request for Segment Customization as per your Business Requirement: https://www.snsinsider.com/reports/breast-conserving-surgery-market-7802
Regional Coverage:
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Request for Country Level Research Report: https://www.snsinsider.com/reports/breast-conserving-surgery-market-7802
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report: